Medpace Holdings, Inc.

Medpace Holdings, Inc.

MEDP·NASDAQ

$450.81

+1.2%
HealthcareMedical - Diagnostics & Research

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

At a Glance

Live Snapshot
Market Cap$12.88B
EPS15.6400
P/E Ratio28.82
Earnings Date07/20/2026

medp

Account Payables

Last Annual Value

28.14M

3-Year CAGR

-5%

5-Year CAGR

1%

10-Year CAGR

12%

Medpace Holdings, Inc.

Medpace Holdings, Inc. Competitors Analysis of Account Payables

MEDP · NASDAQ
CompanyAccount Payables
CAGR 3Y
CAGR 5Y
CAGR 10Y
28.14M
-4.1%1.8%9.9% 
20.54B
8.1%19.9%18.5%
TEM logo
Tempus AI, Inc.
NASDAQ:TEM
81.99M
14.6%19.4%N/A
0.00
N/AN/AN/A
1.60B
61.8%35.0%19.9%
ILMN logo
Illumina, Inc.
NASDAQ:ILMN
240.00M
-0.7%-6.3%5.7%
253.70M
1.5%1.8%7.6%
1.36B
-1.1%0.9%1.4%
HOLX logo
Hologic, Inc.
NASDAQ:HOLX
193.40M
3.3%-2.2%2.1%
Medpace Holdings, Inc.

Medpace Holdings, Inc. Fair Value Envelope

MEDP · NASDAQ

Our analysis suggests that MEDP has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $450.815, this represents a potential HIDDEN relative to our calculated worth for Medpace Holdings, Inc..

Intrinsic Value
Current Price: $450.815